Santen Pharmaceutical (SNPHY) News Today $10.30 +0.47 (+4.78%) As of 03:19 PM Eastern Add Compare Share Share Headlines Stock AnalysisChartFinancialsSEC FilingsShort Interest All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Santen Pharmaceutical Announces Share Buyback PlanNovember 8, 2024 | markets.businessinsider.comSanten Pharmaceutical Co., Ltd. GAAP EPS of Yen 27.85, revenue of Yen 72.34BAugust 6, 2024 | msn.comHere's what to expect from Santen Pharmaceutical's earnings reportAugust 6, 2024 | markets.businessinsider.comSNPHY Stock Earnings: Santen Pharmaceutical Reported Results for Q4 2023May 17, 2024 | investorplace.comSanten Pharmaceutical earnings preview: what to expectMay 9, 2024 | markets.businessinsider.comSanten Pharmaceutical Co LtdApril 23, 2024 | morningstar.comSanten Pharmaceutical Co. Ltd. ADRApril 20, 2024 | wsj.comSanten Pharmaceutical Co. Ltd. (JP3336000009.SG)December 27, 2023 | finance.yahoo.comSanten Pharmaceutical Co. - ADR (SNPHY) Price Target Increased by 7.52% to 10.41October 4, 2023 | msn.comSNPHY Santen Pharmaceutical Co., Ltd.August 9, 2023 | seekingalpha.comSanten Pharmaceutical Co., Ltd. reports Q1 resultsAugust 4, 2023 | msn.comHarrow Acquires Santen's Branded Ophthalmic PortfolioJuly 19, 2023 | benzinga.comSanten Agrees to Licensing Agreements and Asset Transfer for its Pharmaceutical Products in North AmericaJuly 19, 2023 | businesswire.comSanten Pharmaceutical Co. reports FY resultsMay 11, 2023 | msn.comSanten Pharmaceutical is about to announce its earnings — here's what to expectAugust 4, 2022 | markets.businessinsider.comOphthalmology Equipment Market Demand Analysis & Opportunity Outlook 2029July 23, 2022 | marketwatch.comOphthalmology Equipment Market Demand, Opportunity, Outlook, Trends, Revenue, Future Growth Opportunities By2029May 24, 2022 | marketwatch.comSanten Pharmaceutical Co (SNPHY)December 2, 2021 | investing.comSanten Pharmaceutical Co., Ltd. 2021 Q2 - Results - Earnings Call PresentationNovember 11, 2021 | seekingalpha.com Get Santen Pharmaceutical News Delivered to You Automatically Sign up to receive the latest news and ratings for SNPHY and its competitors with MarketBeat's FREE daily newsletter. Email Address SNPHY Media Mentions By Week SNPHY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SNPHY News Sentiment▼0.000.63▲Average Medical News Sentiment SNPHY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SNPHY Articles This Week▼00▲SNPHY Articles Average Week Get Santen Pharmaceutical News Delivered to You Automatically Sign up to receive the latest news and ratings for SNPHY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AZNCF News CMOPF News JCRRF News KYKOF News MAYNF News OPHLY News OTSKF News RHHVF News SNYNF News SCLXW News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:SNPHY) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Santen Pharmaceutical Co., Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Santen Pharmaceutical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
